Effect of the Novel High Affinity Choline Uptake Enhancer 2-(2-Oxopyrrolidin-1-yl)-N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin- 4-yl)acetoamide on Deficits of Water Maze Learning in Rats

Arzneimittel-Forschung/Drug Research

Volumn 46, Issue 4, 1996, Pages 369-373

  Bessho, Tomoko ^a   Takashina, Ken ^a   Tabata, Reiko ^a   Ohshima, Chieko ^a   Chaki, Haruyuki ^a   Yamabe, Haruko ^a   Egawa, Mitsuo ^a   Tobe, Akihiro ^a   Saito, Ken Ichi ^a  

^a MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

2 (2 Oxopyrrolidin 1 yl) N (2,3 dimethyl 5,6,7,8 tetrahydrofuro 2,3 b quinolin 4 yl)acetoamide; CAS 135463 81 9; CAS 1684 40 8; Choline uptake enhancer; MKC 231, pharmacology; Spatial memory; Tacrine

Indexed keywords

2 (2 OXOPYRROLIDIN 1 YL) N (2,3 DIMETHYL 5,6,7,8 TETRAHYDROFURO[2,3 B]QUINOLIN 4 YL]ACETOAMIDE; ACETYLCHOLINESTERASE; CARBACHOL; CHOLINE; CHOLINE UPTAKE ENHANCING AGENT; CHOLINESTERASE INHIBITOR; ETHYLCHOLINE MUSTARD AZIRIDIUM ION; MUSCARINIC RECEPTOR; OXOTREMORINE; PHYSOSTIGMINE; PIRENZEPINE; QUINUCLIDINYL BENZILATE; RADIOLIGAND; TACRINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CHOLINE UPTAKE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG UPTAKE; ENZYME ACTIVITY; HIPPOCAMPUS; HYPOTHERMIA; LEARNING; MALE; MAZE TEST; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SALIVATION; SPATIAL MEMORY; TREMOR;

ACETYLCHOLINESTERASE; ANIMALS; AZIRIDINES; BODY TEMPERATURE; CHOLINE; HIPPOCAMPUS; MALE; MAZE LEARNING; NEUROMUSCULAR BLOCKING AGENTS; NOOTROPIC AGENTS; QUINOLINES; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SALIVATION; TACRINE; TREMOR;

EID: 0029979346     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Drachman, D. A., Leavitt, J., Arch. Neurol. 30, 113 (1974)
2. Drachman, D. A:, Neurology 27, 783 (1977)
3. Perry, E. K., Tomlinson, B. E., Blessed, G. et al., Br. Med. J. II, 1457 (1978)
4. Farlow, M., Gracon, S. I., Hershey, L. A. et al., JAMA 268, 2523 (1992)
5. Kuhar, M. J., Murrin, L. C., J. Neurochem. 30, 15 (1978)
6. Tucek, S., J. Neurochem. 44, 11 (1985)
7. Murrin, L. C., Kuhar, M. J., Mol. Pharmacol. 12, 1082 (1976)
8. Simon, J. R., Kuhar, M. J., Nature 255, 162 (1975)
9. Rylett, R: J., Ball, M. J., Calhoun, E. H., Brain Res. 289, 169 (1983)
10. Sims, N. R., Bowen, D: M., Allen, S. J. et al., J. Neurochem. 40, 503 (1983)
11. Blessed, G., Tolinson, B: E., Roth, M., Br. J. Psychiat. 114, 797 (1968)
12. Neary, D., Snowden, J. S., Mann, D: M. A. et al., J. Neurol., Neurosurg. Psychiatry 49, 229 (1986)
13. Chaki, H., Yamabe, H., Sugano, M. et al., Bioorg. Med. Chem. Let. 14, 1495 (1995)
14. Leventer, S., McKeag, D., Clancy, M. et al., Neuropharmacology 24, 453 (1985)
15. Leventer, S. M., Wulfert, E., Hanin, I., Neuropharmacology 26, 361 (1987)
16. Chrobak, J. J., Hanin, I., Walsh, T: J., Brain Res. 414, 15 (1987)
17. Chrobak, J. J., Hanin, I., Schemechel, D. E. et al., Brain Res. 463, 107 (1988)
18. Morris, R. G. M., The Neurobiology of the Hippocampus, W: Seifert et al., p. 405, Academic Press, London (1983)
19. Fisher, A:, Mantione, C. R., Abraham, D. J. et al., J. Pharmacol. Exp. Ther. 222, 140 (1982)
20. Ellman, G: L., Courtney, K. D:, Andres, J. V: et al., Biochem. Pharmacol. 7, 88 (1961)
21. Yamamura, H. I., Snyder, S. H., Proc. Natl. Acad. Sci. USA 71, 1725 (1974)
22. Watoson, M., William, R., Roeske, R. et al., Life Sci. 31, 2019 (1982)
23. Tamer, A. EL., Corey, J., Wulfert, E. et al., Neuropharmacology 31, 397 (1992)
24. Hunter, A: J., Murray, T. K., Jones, J. A. et al., Br. J. Pharmacol. 98, 79 (1989)
25. Vickroy, T. W., J. Pharmacol. Exp. Ther. 264, 910 (1993)
26. Yamamura, H. I., Snyder, S. H., J. Neurochem. 21, 1355 (1973)
27. Lowenstein, P. R., Coyle, J. T., Brain Res. 381, 191 (1986)
28. Rylett, B. J., Colhoun, E. H., J. Neurochem. 34, 713 (1980)
29. Haroutunian, V., Barnes, E., Davis, K. L., Psychopharmacology 87, 266 (1985)
30. Nabeshima, T., Yoshida, S., Kameyama, T., Eur. J. Pharmacol. 154, 263 (1988)
31. Wanibuchi, F., Nishida, T., Yamashita, H. et al., Eur. J. Pharmacol. 265, 151 (1994)
32. Tarricone, B. J., Keim, S. R., Simon, J. R. et al., Brain Res. 548, 55 (1991)
33. Bessho, T., Takashina, K., Ohshima, C. et al., Jpn. J. Pharmacol. 64 Suppl. I), 230P (1994)
34. Sarter, M., Bruno, J. P., Dudchenko, P., Pschopharmacology 101, 1 (1990)
35. Kwo-On-Yuen, P. F., Mandel, R., Chen, A. D. et al., Exp. Neurol. 108, 221 (1990)
36. Nabeshima, T., Maruyama, E., Katoh, A. et al., Jpn. J. Pharmacol. 57, 311 (1991)
37. Hagan, J. J., Jansen, J. H. M., Broekkamp, C. L. E., Psychopharmacology 98, 347 (1989)
38. Smith, G., Brain Res. Rev. 13 103 (1988)
39. Yoshida, S., Suzuki, N., Eur. J. Pharmacol. 250, 117 (1993)